BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 21535978)

  • 1. [Hyperfibrinolysis as the cause of haemorrhage and increased mortality in trauma patients].
    Wikkelsø AJ; Afshari A; Stensballe J; Johansson PI
    Ugeskr Laeger; 2011 May; 173(18):1284-7. PubMed ID: 21535978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and impact of hyperfibrinolysis in trauma.
    Schöchl H; Voelckel W; Solomon C
    Wien Klin Wochenschr; 2010 Dec; 122 Suppl 5():S11-3. PubMed ID: 21598439
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperfibrinolysis elicited via thromboelastography predicts mortality in trauma.
    Ives C; Inaba K; Branco BC; Okoye O; Schochl H; Talving P; Lam L; Shulman I; Nelson J; Demetriades D
    J Am Coll Surg; 2012 Oct; 215(4):496-502. PubMed ID: 22766227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tranexamic acid is associated with reduced complement activation in trauma patients with hemorrhagic shock and hyperfibrinolysis on thromboelastography.
    Barrett CD; Vigneshwar N; Moore HB; Ghasabyan A; Chandler J; Moore EE; Yaffe MB
    Blood Coagul Fibrinolysis; 2020 Dec; 31(8):578-582. PubMed ID: 32732500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful rotational thromboelastometry-guided treatment of traumatic haemorrhage, hyperfibrinolysis and coagulopathy.
    Brenni M; Worn M; Brüesch M; Spahn DR; Ganter MT
    Acta Anaesthesiol Scand; 2010 Jan; 54(1):111-7. PubMed ID: 19860752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmin thrombelastography rapidly identifies trauma patients at risk for massive transfusion, mortality, and hyperfibrinolysis: A diagnostic tool to resolve an international debate on tranexamic acid?
    Barrett CD; Moore HB; Vigneshwar N; Dhara S; Chandler J; Chapman MP; Sauaia A; Moore EE; Yaffe MB
    J Trauma Acute Care Surg; 2020 Dec; 89(6):991-998. PubMed ID: 33230046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperfibrinolysis diagnosed with rotational thromboelastometry and treated with tranexamic acid in a dog with acute traumatic coagulopathy.
    Muri B; Schmierer P; Schwarz A; Sigrist N
    Schweiz Arch Tierheilkd; 2018 Apr; 160(4):227-233. PubMed ID: 29615381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolysis and antifibrinolytic treatment in the trauma patient.
    Gall LS; Davenport RA
    Curr Opin Anaesthesiol; 2018 Apr; 31(2):227-233. PubMed ID: 29324486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemorrhages caused by hyperfibrinolysis and their treatment].
    Teofili MT; Tucci G
    Clin Ter; 1968 Sep; 46(6):563-84. PubMed ID: 4914362
    [No Abstract]   [Full Text] [Related]  

  • 10. Emerging treatment strategies for trauma-induced coagulopathy.
    Sorensen B; Fries D
    Br J Surg; 2012 Jan; 99 Suppl 1():40-50. PubMed ID: 22441854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of resuscitation fluids, fresh frozen plasma and antifibrinolytics on fibrinolysis in a thrombelastography-based, in-vitro, whole-blood model.
    Kostousov V; Wang YW; Cotton BA; Wade CE; Holcomb JB; Matijevic N
    Blood Coagul Fibrinolysis; 2013 Jul; 24(5):489-97. PubMed ID: 23406662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of fibrinogen in massive injury.
    Maung AA; Kaplan LJ
    Minerva Anestesiol; 2014 Jan; 80(1):89-95. PubMed ID: 23857437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tranexamic acid for trauma-related hemorrhage.
    Bailey AM; Baker SN; Weant KA
    Adv Emerg Nurs J; 2014; 36(2):123-31; quiz 132-3. PubMed ID: 24785665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational model of tranexamic acid on urokinase mediated fibrinolysis.
    Wu TB; Orfeo T; Moore HB; Sumislawski JJ; Cohen MJ; Petzold LR
    PLoS One; 2020; 15(5):e0233640. PubMed ID: 32453766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Traumatic coagulopathies.
    Chico Fernández M; Mudarra Reche C
    Med Intensiva (Engl Ed); 2019 Nov; 43(8):497-499. PubMed ID: 30287087
    [No Abstract]   [Full Text] [Related]  

  • 16. Should antifibrinolytics be given in all patients with trauma?
    Levi M
    Curr Opin Anaesthesiol; 2012 Jun; 25(3):385-8. PubMed ID: 22459985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severely injured trauma patients with admission hyperfibrinolysis: Is there a role of tranexamic acid? Findings from the PROPPR trial.
    Khan M; Jehan F; Bulger EM; OʼKeeffe T; Holcomb JB; Wade CE; Schreiber MA; Joseph B;
    J Trauma Acute Care Surg; 2018 Nov; 85(5):851-857. PubMed ID: 29985230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal Transitions in Fibrinolysis after Trauma: Adverse Outcome Is Principally Related to Late Hypofibrinolysis.
    Rossetto A; Vulliamy P; Lee KM; Brohi K; Davenport R
    Anesthesiology; 2022 Jan; 136(1):148-161. PubMed ID: 34724559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperfibrinolysis diagnosed by rotational thromboelastometry in a case of suspected amniotic fluid embolism.
    Collins NF; Bloor M; McDonnell NJ
    Int J Obstet Anesth; 2013 Jan; 22(1):71-6. PubMed ID: 23159521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant tissue-type plasminogen activator-evoked hyperfibrinolysis is enhanced by acidosis and inhibited by hypothermia but still can be blocked by tranexamic acid.
    Dirkmann D; Radü-Berlemann J; Görlinger K; Peters J
    J Trauma Acute Care Surg; 2013 Feb; 74(2):482-8. PubMed ID: 23354242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.